DAVID C HASTINGS
CIK 1237401 · Chief Financial Officer · last filed 2026-01-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.28M
Companies
6
Total Filings
50
Lifetime Open-Market Net
-$25.66M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TRVI | Chief Financial Officer | — | $14.21 | — | $0 | 1 | 2026-01-12 |
| SCYX | Director | 69,183 | $4.23 | $292.6K | $55.0K | 16 | 2025-06-30 |
| ABUS | Chief Financial Officer | 249,824 | $4.26 | $1.06M | -$95.0K | 9 | 2025-02-19 |
| Entasis Therapeutics Holdings Inc. (ETTX) Delisted | Director | 0 | $2.19 | $0 | $0 | 7 | 2022-07-11 |
| Unilife Corp (UNIS) Delisted | See Remarks | 300,000 | — | — | $0 | 2 | 2017-01-30 |
| INCY | Chief Financial Officer | 8,500 | $108.53 | $922.5K | -$25.62M | 15 | 2014-02-18 |
Recent Filings · Page 2 of 5
50 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-22 | SCYX | Grant (A) | +10,000 | $0 | EDGAR |
| 2022-02-15 | Entasis Therapeutics Holdings Inc. (ETTX) Delisted | Mixed | — | $0 | EDGAR |
| 2022-01-20 | ABUS | Grant (A) | — | $0 | EDGAR |
| 2022-01-19 | Entasis Therapeutics Holdings Inc. (ETTX) Delisted | Grant (A) | +27,500 | $0 | EDGAR |
| 2021-06-21 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2021-04-02 | Entasis Therapeutics Holdings Inc. (ETTX) Delisted | Grant (A) | +22,000 | $0 | EDGAR |
| 2021-03-31 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2021-02-17 | ABUS | Grant (A) | — | $0 | EDGAR |
| 2020-10-06 | Entasis Therapeutics Holdings Inc. (ETTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-08 | SCYX | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.